The Gross Margin of Takeda Pharmaceutical Co Ltd (4502.T) is 65.51%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2025-03-31 | 65.51% |
| 2024-03-31 | 66.54% |
| 2023-03-31 | 69.11% |
| 2022-03-31 | 68.99% |
| 2021-03-31 | 68.91% |
| 2020-03-31 | 66.89% |
| 2019-03-31 | 68.92% |
| 2018-03-31 | 71.99% |
| 2017-03-31 | 67.74% |
| 2016-03-31 | 70.38% |